Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group

Osteoarthritis and Cartilage

Volumn 19, Issue 5, 2011, Pages 606-610

  Conaghan, P G ^a,b   Hunter, D J ^c,d   Maillefert, J F ^e,f,g   Reichmann, W M ^h,i   Losina, E ^h,i  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Chapel Allerton Hospital   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NEW ENGLAND BAPTIST HOSPITAL   (United States)

^e DIJON UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE BOURGOGNE   (France)

^g INSERM   (France)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Conventional radiography; Magnetic resonance imaging; Osteoarthritis; Reliability; Responsiveness; Validity

Indexed keywords

ARTICLE; BONE MARROW; CLINICAL ASSESSMENT; CONSENSUS DEVELOPMENT; CONSTRUCT VALIDITY; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FOOD AND DRUG ADMINISTRATION; HUMAN; IMAGING; INFORMATION RETRIEVAL; JOINT CAVITY; LONG TERM CARE; METRIC SYSTEM; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PATHOLOGY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RELIABILITY; SYNOVITIS; X RAY FILM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROGRAPHY; CARTILAGE, ARTICULAR; HUMANS; JOINTS; MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 79955869385     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2011.02.018     Document Type: Article

References (22)

1. Ackerman I.N., Dieppe P.A., March L.M., Roos E.M., Nilsdotter A.K., Brown G.C., et al. Variation in age and physical status prior to total knee and hip replacement surgery: a comparison of centers in Australia and Europe. Arthritis Rheum 2009, 61:166-173.
2. Hawker G.A. Who, when, and why total joint replacement surgery? The patient's perspective. Curr Opin Rheumatol 2006, 18:526-530.
3. FDA Clinical Development Programs for Drugs, Devices and Biological Products Intended for the Treatment of OA 1999.
4. CHMP Points to Consider - Clinical Investigation of Medicinal Products Used in the Treatment of OA 1998.
5. CHMP Guideline on Clinical Investigation of Medicinal Products Used in the Treatment of Osteoarthritis 2010.
6. Mazzuca S.A., Brandt K.D. Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis. Rheum Dis Clin North Am 1999, 25:467-480.
7. Brandt K.D., Mazzucca S.A. Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs. Arthritis Rheum 2005, 52:3349-3359.
8. Guermazi A., Burstein D., Conaghan P., Eckstein F., Hellio Le Graverand-Gastineau M.P., Keen H., et al. Imaging in osteoarthritis. Rheum Dis Clin North Am 2008, 34:645-687.
9. Wenham C.Y., Conaghan P.G. Imaging the painful osteoarthritic knee joint: what have we learned?. Nat Clin Pract Rheumatol 2009, 5:149-158.
10. Brandt K.D., Mazzucca S.A., Katz B.P., Lane K.A., Buckwalter K.A., Yocum D.E., et al. Effects of doxycycline on progression of osteoarthritis: results of a randomised, placebo-controlled, double-blind trial. Arthritis Rheum 2005, 52:2015-2025.
11. Bingham C.O., Buckland-Wright J.C., Garnero P., Cohen S.B., Dougados M., Adami S., et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006, 54:3494-3507.
12. Amin S., LaValley M.P., Guermazi A., Grigoryan M., Hunter D.J., Clancy M., et al. The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis Rheum 2005, 52:3152-3159.
13. Hunter D.J., Le Graverand M.P., Eckstein F. Radiologic markers of osteoarthritis progression. Curr Opin Rheumatol 2009, 21:110-117.
14. Hunter D.J., Zhang Y.Q., Tu X., LaValley M., Niu J.B., Amin S., et al. Change in joint space width: hyaline articular cartilage loss or alteration in meniscus?. Arthritis Rheum 2006, 54:2488-2495.
15. Brandt K.D., Radin E.L., Dieppe P.A., van de Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis 2006, 65:1261-1264.
16. Hellio Le Graverand-Gastineau M.P. OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?. Osteoarthritis Cartilage 2009, 17:1393-1401.
17. Reichmann W.M., Maillefert J.F., Hunter D.J., Conaghan P.G., Katz J.N., Losina E. Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review. Osteoarthritis Cartilage 2011, 19:550-556.
18. Chu Miow Lin D., Reichmann W.M., Gossec L., Losina E., Conaghan P.G., Maillefert J.F. Validity and responsiveness of radiographic joint space width metric measurement in hip osteoarthritis: a systematic review. Osteoarthritis Cartilage 2011, 19:543-549.
19. Hunter D.J., Zhang W., Conaghan P.G., Hirko K., Menashe L., Reichmann W.M., Losina E. Responsiveness and reliability of MRI in knee osteoarthritis: a meta-analysis of published evidence. Osteoarthritis Cartilage 2011, 19:589-605.
20. Hunter D., Zhang W., Conaghan P.G., Hirko K., Menashe L., Li L., Reichmann W.M., Losina E. Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. Osteoarthritis Cartilage 2011, 19:557-588.
21. Keen H.I., Wakefield R.J., Conaghan P.G. A systematic review of ultrasonography in osteoarthritis. Ann Rheum Dis 2009, 68:611-619.
22. Neogi T., Felson D., Niu J., Nevitt M., Lewis C.E., Aliabadi P., et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 2009, 339:b2844.